Unveiling 11 Analyst Insights On Bristol-Myers Squibb
Unveiling 11 Analyst Insights On Bristol-Myers Squibb
揭示了有关施贵宝的11个分析师见解
The analysis of recent analyst actions...11 analysts have shared their evaluations of Bristol-Myers Squibb (NYSE:BMY) during the recent three months, expressing a mix of bullish and bearish perspectives.
在最近三个月内，有11位分析师针对施贵宝（纽交所:BMY）进行了评估，表达了看好和看淡观点的混合态度。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天内情绪的变化，并将它们与前几个月进行比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $48.0, a high estimate of $59.00, and a low estimate of $41.00. This current average reflects an increase of 2.32% from the previous average price target of $46.91.
分析师对12个月的目标价格的见解显示，平均目标为48.0美元，最高估值为59.00美元，最低估值为41.00美元。当前平均数反映了与之前46.91美元的平均目标价格相比的2.32%的增长。
Decoding Analyst Ratings: A Detailed Look
分析师评级解读：详细解析
The analysis of recent analyst actions...
最近分析师行...
登录免费看全文
登录/注册
资讯热榜
更新时间